Shamik J. Parikh net worth and biography

Shamik Parikh Biography and Net Worth

Chief Medical Officer of Humacyte

Dr. Parikh is an experienced medical professional with nearly two decades of biopharmaceutical experience leading teams across Clinical Strategy and Development, Medical Affairs, and Patient Safety. After receiving his medical degree from the Topiwala National Medical College in Mumbai, India, he completed his post-graduate training in the US in internal medicine and pediatrics, followed by a clinical fellowship in endocrinology at the NIH.

What is Shamik J. Parikh's net worth?: The estimated net worth of Shamik J. Parikh is at least $9.75 thousand as of April 10th, 2025. Dr. Parikh owns 7,500 shares of Humacyte stock worth more than $9,750 as of December 4th. This net worth evaluation does not reflect any other investments that Dr. Parikh may own. Additionally, Dr. Parikh receives a salary of $514,720.00 as Chief Medical Officer at Humacyte. Learn More about Shamik J. Parikh's net worth.
How old is Shamik J. Parikh?: Dr. Parikh is currently 51 years old. There are 5 older executives and no younger executives at Humacyte. The oldest executive at Humacyte is Mr. Dale A. Sander, CFO, Chief Corporate Development Officer & Treasurer, who is 64 years old. Learn More on Shamik J. Parikh's age.
What is Shamik J. Parikh's salary?: As the Chief Medical Officer of Humacyte, Inc., Dr. Parikh earns $514,720.00 per year. There are 3 executives that earn more than Dr. Parikh. The highest earning executive at Humacyte is Dr. Laura E. Niklason M.D., Ph.D., Founder, President, CEO & Director, who commands a salary of $899,250.00 per year. Learn More on Shamik J. Parikh's salary.
How do I contact Shamik J. Parikh?: The corporate mailing address for Dr. Parikh and other Humacyte executives is 1177 AVENUE OF THE AMERICAS 5TH FLOOR, NEW YORK NY, 10036. Humacyte can also be reached via phone at 919-313-9633 and via email at [email protected]. Learn More on Shamik J. Parikh's contact information.
Has Shamik J. Parikh been buying or selling shares of Humacyte?: Shamik J. Parikh has not been actively trading shares of Humacyte during the last ninety days. Most recently, on Thursday, April 10th, Shamik J. Parikh bought 7,500 shares of Humacyte stock. The stock was acquired at an average cost of $1.55 per share, with a total value of $11,625.00. Following the completion of the transaction, the insider now directly owns 7,500 shares of the company's stock, valued at $11,625. Learn More on Shamik J. Parikh's trading history.
Who are Humacyte's active insiders?: Humacyte's insider roster includes Michael Constantino (Director), Brady Dougan (Director), Laura Niklason (CEO), Shamik Parikh (Chief Medical Officer), Heather Prichard (COO), Dale Sander (CFO), William Scheessele (Chief Commercial Officer), and Kathleen Sebelius (Director). Learn More on Humacyte's active insiders.
Are insiders buying or selling shares of Humacyte?: During the last twelve months, Humacyte insiders bought shares 5 times. They purchased a total of 88,593 shares worth more than $138,418.22. During the last twelve months, insiders at the sold shares 6 times. They sold a total of 4,482,090 shares worth more than $7,466,382.20. The most recent insider tranaction occured on August, 20th when Director Brady W Dougan sold 591,685 shares worth more than $934,862.30. Insiders at Humacyte own 5.1% of the company. Learn More about insider trades at Humacyte.
Information on this page was last updated on 8/20/2025.

Shamik J. Parikh Insider Trading History at Humacyte

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
4/10/2025	Buy	7,500	$1.55	$11,625.00	7,500

Shamik J. Parikh Buying and Selling Activity at Humacyte

Humacyte Company Overview

Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs) to be implanted into patient without inducing a foreign body response or leading to immune rejection. It is developing a portfolio of HAVs, which would target the vascular repair, reconstruction, and replacement market, including vascular trauma; arteriovenous access for hemodialysis; peripheral arterial disease; pediatric heart surgery; and coronary artery bypass grafting, as well as for the delivery of cellular therapy, including pancreatic islet cell transplantation to treat Type 1 diabetes. The company was founded in 2004 and is headquartered in Durham, North Carolina.

Today's Range

Now: $1.30

$1.26

$1.33

50 Day Range

MA: $1.53

$1.12

$2.48

2 Week Range

Now: $1.30

$1.09

$6.77

Volume

3,077,595 shs

Average Volume

4,793,646 shs

Market Capitalization

$243.45 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.9

Shamik Parikh Biography and Net Worth

What is Shamik J. Parikh's net worth?

How old is Shamik J. Parikh?

What is Shamik J. Parikh's salary?

How do I contact Shamik J. Parikh?

Has Shamik J. Parikh been buying or selling shares of Humacyte?

Who are Humacyte's active insiders?

Are insiders buying or selling shares of Humacyte?